Preferred Label : Thyroid cancer, nonmedullary, 2;
Symbol : NMTC2;
CISMeF acronym : NMTC2;
Type : Phenotype, molecular basis known;
Description : Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin
and accounts for more than 95% of all thyroid cancer cases (summary by Vriens et al.,
2009). The remaining cancers originate from parafollicular cells (medullary thyroid
cancer, MTC; 155240). NMTC is classified into 4 groups: papillary (188550), follicular,
Hurthle cell (607464), and anaplastic. Approximately 5% of;
Inheritance : Autosomal dominant; Somatic mutation;
Molecular basis : Susceptibility conferred by mutation in the slit-robo GTPase-activating protein, rho,
1 gene (SRGAP1, 606523.0001);
Neoplasia : Nonmedullary thyroid carcinoma (papillary and follicular);
Prefixed ID : #188470;
Origin ID : 188470;
UMLS CUI : C4225426;
Automatic exact mappings (from CISMeF team)
- Broader ORDO disease(s)
- Currated CISMeF NLP mapping
- DO Cross reference
- Genes related to phenotype
- HPO term(s)
- ORDO concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- Validated automatic mappings to BTNT
- Validated automatic mappings to NTBT
